A Groundbreaking Milestone in the Treatment of NASH and Liver Fibrosis - Anervea Pune, March 17, 2024 (GLOBE NEWSWIRE) -- The recent FDA approval of Resmetirom, developed by Madrigal Pharmaceuticals, has sent ripples of excitement throughout the medical community, marking a...

Empowering Anervea: A Catalyst for Transformative Insights in the Pharmaceutical Arena Pune, March 04, 2024 (GLOBE NEWSWIRE) -- In an era where the pharmaceutical industry's landscape is rapidly evolving, competitive intelligence (CI) has emerged as a cornerstone for companies...

Revolutionizing Pharma Commercial Analytics: Harnessing the Power of Patient Claims Data - Anervea Pune, Feb. 29, 2024 (GLOBE NEWSWIRE) -- In an era where data is pivotal, the pharma industry stands at the cusp of a significant transformation powered by the extensive utilization of patient claims...

Anervea Spearheads Growth in India's Booming Dermatology Market Post-COVID, Aiming to Enhance Pharmaceutical Sales and Marketing Effectiveness Anervea, a leading analytics service provider, is at the forefront of transforming the dermatology market landscape in India.